Enveric Biosciences
ENVB
13 hedge funds and large institutions have $345K invested in Enveric Biosciences in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 6 closing their positions.
7% less funds holding
Funds holding: 14 → 13 (-1)
10.61% less ownership
Funds ownership: 10.61% → 0% (-11%)
11% less capital invested
Capital invested by funds: $387K → $345K (-$42K)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$145K |
| 2 |
HF
HRT Financial
New York
|
+$117K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$108K |
| 4 |
VF
Virtu Financial
New York
|
+$63.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$11.4K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$7.89K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.51K |
| 4 |
Two Sigma Investments
New York
|
-$4.35K |
| 5 |
Jane Street
New York
|
-$3.88K |
ENVB Hedge Fund Activity: Q1 2025 in Review
13 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q1 2025, worth a combined $345K — down 11% from $387K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ENVB and 5 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 6 added.
The largest buyer was AdvisorShares Investments, adding an estimated $145K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $11.4K sold.
- 13 institutional investors held Enveric Biosciences (ENVB) as of Q1 2025, down from 14 in Q4 2024.
- Funds reported $345K of Enveric Biosciences stock for Q1 2025, down 11% quarter-over-quarter.
- 5 funds opened new Enveric Biosciences positions in Q1 2025 and 6 closed out, a net change of -1 holder.
- The largest Enveric Biosciences buyer in Q1 2025 was AdvisorShares Investments, an estimated $145K added.
- The largest Enveric Biosciences seller in Q1 2025 was Two Sigma Securities, an estimated $11.4K sold.
Based on aggregated 13F filings for Q1 2025.